Biopharmaceutical New Technologies expect that the first a cancer vaccine will be approved by 2030

@
Show original
It will contain small genetic codes which will teach to fight an organism against cancer cells...
Analysis
×
Ugur Shakhin
Last position: Founder, CEO (BioNTech SE)
BioNTech SE
Main activity:Health care and social services